Menu
GWAS Study

Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation.

Soler Artigas M, Wain LV, Miller S et al.

26635082 PubMed ID
GWAS Study Type
97811 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SA
Soler Artigas M
WL
Wain LV
MS
Miller S
KA
Kheirallah AK
HJ
Huffman JE
NI
Ntalla I
SN
Shrine N
OM
Obeidat M
TH
Trochet H
MW
McArdle WL
AA
Alves AC
HJ
Hui J
ZJ
Zhao JH
JP
Joshi PK
TA
Teumer A
AE
Albrecht E
IM
Imboden M
RR
Rawal R
LL
Lopez LM
MJ
Marten J
ES
Enroth S
SI
Surakka I
PO
Polasek O
LL
Lyytikäinen LP
GR
Granell R
HP
Hysi PG
FC
Flexeder C
MA
Mahajan A
BJ
Beilby J
BY
Bossé Y
BC
Brandsma CA
CH
Campbell H
GC
Gieger C
GS
Gläser S
GJ
González JR
GH
Grallert H
HC
Hammond CJ
HS
Harris SE
HA
Hartikainen AL
HM
Heliövaara M
HJ
Henderson J
HL
Hocking L
HM
Horikoshi M
HN
Hutri-Kähönen N
IE
Ingelsson E
Johansson Å
KJ
Kemp JP
KI
Kolcic I
KA
Kumar A
LL
Lind L
ME
Melén E
MA
Musk AW
NP
Navarro P
ND
Nickle DC
PS
Padmanabhan S
RO
Raitakari OT
RJ
Ried JS
RS
Ripatti S
SH
Schulz H
SR
Scott RA
SD
Sin DD
SJ
Starr JM
VA
Viñuela A
VH
Völzke H
WS
Wild SH
WA
Wright AF
ZT
Zemunik T
JD
Jarvis DL
ST
Spector TD
ED
Evans DM
LT
Lehtimäki T
VV
Vitart V
KM
Kähönen M
GU
Gyllensten U
RI
Rudan I
DI
Deary IJ
KS
Karrasch S
PN
Probst-Hensch NM
HJ
Heinrich J
SB
Stubbe B
WJ
Wilson JF
WN
Wareham NJ
JA
James AL
MA
Morris AP
JM
Jarvelin MR
HC
Hayward C
SI
Sayers I
SD
Strachan DP
HI
Hall IP
TM
Tobin MD
Chapter II

Abstract

Summary of the research findings

Lung function measures are used in the diagnosis of chronic obstructive pulmonary disease. In 38,199 European ancestry individuals, we studied genome-wide association of forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC with 1000 Genomes Project (phase 1)-imputed genotypes and followed up top associations in 54,550 Europeans. We identify 14 novel loci (P<5 × 10(-8)) in or near ENSA, RNU5F-1, KCNS3, AK097794, ASTN2, LHX3, CCDC91, TBX3, TRIP11, RIN3, TEKT5, LTBP4, MN1 and AP1S2, and two novel signals at known loci NPNT and GPR126, providing a basis for new understanding of the genetic determinants of these traits and pulmonary diseases in which they are altered.

38,199 European ancestry adults

Chapter III

Study Statistics

Key metrics and study information

97811
Total Participants
GWAS
Study Type
Yes
Replicated
54,550 European ancestry adults, 5,062 children
Replication Participants
European
Ancestry
Australia, Germany, Switzerland, Finland, U.K., Croatia, Sweden
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.